The University of Chicago Header Logo

Connection

Rita Nanda to Insulin-Like Growth Factor II

Back to Details
This is a "connection" page, showing publications Rita Nanda has written about Insulin-Like Growth Factor II.
Rita Nanda
Connection Strength
0.027
Insulin-Like Growth Factor II
  1. A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat. 2013 May; 139(1):145-53.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.